Showing results (61-70 of 180) with videos related to

Sort By:
Pageof 18
Cancer Medicine|November 26, 2020
Allogeneic stem cell transplant in patients with acute myeloid leukemia and karnofsky performance status score less than or equal to 80%: A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation (EBMT)Francesco Saraceni, Myriam Labopin, Edouard Forcade, et al.
Bone Marrow Transplantation|November 22, 2025
Outcomes of allogeneic hematopoietic stem cell transplantation from different donor types in primary refractory acute myeloid leukemia: a report from the ALWP of the EBMTKordelia Barbullushi, Myriam Labopin, Nicolaus Kröger, et al.
JCI Insight|December 21, 2018
OX40L/OX40 axis impairs follicular and natural Treg function in human SLEClément Jacquemin, Jean-François Augusto, Marc Scherlinger, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 29, 2025
Updates on Donor-Derived Infection in Solid Organ Transplantation, Report from the 2024 GTI (Infection and Transplantation Group) Annual MeetingCarole Eldin, Paolo Antonio Grossi, Victoria Manda, et al.
American Journal of Hematology|December 27, 2019
The impact of concomitant cytogenetic abnormalities on acute myeloid leukemia with monosomy 7 or deletion 7q after HLA-matched allogeneic stem cell transplantationXavier Poiré, Myriam Labopin, Emmanuelle Polge, et al.
British Journal of Haematology|August 7, 2025
Impact of the addition of antithymocyte globulin to post-transplantation cyclophosphamide in haploidentical transplantation with peripheral blood compared to post-transplantation cyclophosphamide alone: A retrospective study on behalf of the Cellular Therapy and Immunobiology Working Party of the European Society for Blood and Marrow TransplantationAntoine Capes, Jarl E Mooyaart, Didier Blaise, et al.
The Lancet. Haematology|July 30, 2026
Haematopoietic cell transplantation for relapsed or refractory classical Hodgkin lymphoma: a retrospective, registry-based cohort study of 19 498 patients from the EBMT Lymphoma Working GroupAli Bazarbachi, Mathilde Fekom, Carmen Martinez, et al.
Bone Marrow Transplantation|October 13, 2020
Tandem autologous-reduced intensity allogeneic stem cell transplantation in high-risk relapsed Hodgkin lymphoma: a retrospective study of the Lymphoma Working Party-EBMTLeyre Bento, Ariane Boumendil, Hervé Finel, et al.
American Journal of Hematology|September 18, 2020
The impact of cytogenetic risk on the outcomes of allogeneic hematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukemia: On behalf of the acute leukemia working party (ALWP) of the European group for blood and marrow transplantation (EBMT)Monica Poiani, Myriam Labopin, Giorgia Battipaglia, et al.
European Journal of Haematology|September 24, 2022
Salvage haploidentical or cord-blood allogeneic stem cell transplantation after a prior alternative allograft in hematologic malignancies: A retrospective study from the SFGM-TCDoriane Cavalieri, Marie-Thérèse Rubio, Alexandrine Corriger, et al.
Pageof 18